NEW YORK – NanoView Biosciences said on Wednesday that it has signed an exclusive agreement with Quantum Design to distribute its ExoView platform in China.
The research-use-only ExoView platform is an antibody labeling and imaging-based tool that offers high-resolution sizing, counting, and phenotyping of extracellular vesicles and viral vectors. Boston-based NanoView noted that the platform requires low sample input, no extensive sample preparation or purification, and minimal hands-on time.